HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Joan E Lipa Selected Research

growth factor-activatable Na-H exchanger NHE-1

1/2009Na+/H+ exchange inhibitor cariporide attenuates skeletal muscle infarction when administered before ischemia or reperfusion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Joan E Lipa Research Topics

Disease

7Neoplasms (Cancer)
01/2018 - 01/2004
6Ischemia
03/2013 - 12/2005
4Infarction (Infarctions)
03/2013 - 12/2005
3Reperfusion Injury
03/2013 - 08/2008
2COVID-19
02/2022 - 11/2021
2Lymphoma (Lymphomas)
10/2021 - 01/2019
2Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
10/2021 - 01/2019
2Breast Neoplasms (Breast Cancer)
08/2017 - 01/2007
2Contracture
04/2016 - 02/2010
1B-Cell Lymphoma (Lymphoma, B Cell)
10/2021
1Inflammation (Inflammations)
10/2021
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
10/2021
1Cicatrix (Scar)
04/2016
1Hypoxia (Hypoxemia)
07/2012
1Weight Loss (Weight Reduction)
10/2010
1Venous Thrombosis (Deep-Vein Thrombosis)
10/2008
1Fat Necrosis
08/2004
1Hernia (Hernias)
08/2004
1Melanoma (Melanoma, Malignant)
01/2004
1Sarcoma (Soft Tissue Sarcoma)
01/2004
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2004
1Thrombosis (Thrombus)
11/2003
1Necrosis
03/2003

Drug/Important Bio-Agent (IBA)

5Adenosine Triphosphate (ATP)IBA
03/2013 - 12/2005
2Capsules (Microcapsules)IBA
10/2021 - 01/2019
2Pharmaceutical PreparationsIBA
03/2013 - 12/2005
21- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
07/2012 - 08/2008
2Mitochondrial Permeability Transition PoreIBA
07/2012 - 08/2008
1Anaplastic Lymphoma KinaseIBA
10/2021
1FibrinIBA
10/2021
1Phenobarbital (Luminal)FDA Link
01/2019
1PlasticsIBA
08/2017
1Nicorandil (SG 75)IBA
03/2013
1Potassium Channels (Potassium Channel)IBA
03/2013
1HEPESIBA
07/2012
1BuffersIBA
07/2012
1Vasodilator Agents (Vasodilators)IBA
01/2012
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2012
1human VEGFA proteinIBA
01/2012
1Hemoglobins (Hemoglobin)IBA
10/2010
1Crystalloid SolutionsIBA
10/2010
1cariporideIBA
01/2009
1growth factor-activatable Na-H exchanger NHE-1IBA
01/2009
1Peroxidase (Myeloperoxidase)IBA
08/2008
1AtractylosideIBA
08/2008
1Cyclosporine (Ciclosporin)FDA LinkGeneric
08/2008
1(melle-4)cyclosporinIBA
08/2008
1Glyburide (Glibenclamide)FDA LinkGeneric
12/2005
1N- cyano- N'- (1,1- dimethylpropyl)- N''- (3- pyridinyl)guanidineIBA
12/2005
1HMR 1098IBA
12/2005
15-hydroxydecanoic acidIBA
12/2005
1Dihydrotachysterol (AT 10)IBA
12/2005
1StreptokinaseFDA Link
11/2003
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
11/2003

Therapy/Procedure

5Mammaplasty (Breast Reconstruction)
02/2022 - 08/2004
5Free Tissue Flaps
10/2008 - 03/2003
4Radiotherapy
01/2018 - 01/2004
3Breast Implants (Breast Implant)
10/2021 - 02/2010
2Intravenous Administration
03/2013 - 01/2009
2Intravenous Injections
08/2008 - 12/2005
1Segmental Mastectomy (Lumpectomy)
01/2018
1Mastectomy (Mammectomy)
08/2017
1Prostheses and Implants (Prosthesis)
04/2016
1Transplantation
03/2013
1Ischemic Postconditioning
07/2012
1Therapeutics
01/2012
1Anesthesia
10/2010
1Length of Stay
10/2010
1Tissue Expansion Devices (Tissue Expander)
02/2010
1Chemoprevention
01/2007
1Intravenous Infusions
12/2005
1Skin Transplantation (Skin Grafting)
03/2003